GO
Loading...

Pfizer Prevails in Patent Suit Against Teva

Pfizer said on Tuesday that a U.S. federal court upheld the three main patents covering its Celebrex painkiller, winning a challenge by generic drugmaker Teva Pharmaceutical Industries.

The decision bars Teva from launching a competitor drug in the U.S. until December 2015, Pfizer said.

Symbol
Price
 
Change
%Change
PFE
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video